Product Information
IVERMECTIN 3 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $1.9942 per EA under NDC 72888020666. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Jan 22, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888020666
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IVERMECTINApproval Type
Generic (ANDA)
FDA Application
ANDA215922FDA Approved
1/22/2025
TE Code
AB
On Market Since
1/22/2025
Pharmacological Classes
Price Statistics
The NADAC for IVERMECTIN 3 MG TABLET has been published 69 times since Jun 11, 2025, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9942 per EA |
|---|---|
| All-time high | $3.2331 (Jun 11, 2025) |
| All-time low | $1.9942 (Sep 23, 2026) |
| 52-week high | $3.1722 |
| 52-week low | $1.9942 |
| Median price | $2.8405 |
| Average price | $2.6731 |
| Largest weekly change | -7.8% (Feb 18, 2026) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ivermectin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiparasitic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IVERMECTIN 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVERMECTIN 3 MG TABLET, manufactured by Advagen Pharma Ltd., is $1.9942 per EA (NDC 72888020666), effective Sep 30, 2026.
How has the price of IVERMECTIN 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVERMECTIN 3 MG TABLET has declined 38.3%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for IVERMECTIN 3 MG TABLET?
Since Jun 11, 2025, the NADAC for IVERMECTIN 3 MG TABLET has ranged from a low of $1.9942 (Sep 23, 2026) to a high of $3.2331 (Jun 11, 2025), with a median of $2.8405 per EA.
Are there cheaper alternatives to IVERMECTIN 3 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as IVERMECTIN 3 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IVERMECTIN 3 MG TABLET?
IVERMECTIN 3 MG TABLET (NDC 72888020666) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.